发明名称 SUSTAINED DRUG RELEASE COMPOSITION
摘要 <p>The invention relates to a sustained release formulation for delivering one or more pharmaceutically active agents The formulation comprises cross-linked high amylose starch and at least one pharmaceutically active agent, and, when subdivided into smaller dosage forms, the smaller dosage forms have substantially the same sustained release properties as the formulation from which they were derived The formulations can provide sustained release for up to at least 24 hours, and because of their divisability permits a recipient of the active agent or the person administering the active agent to titrate the dosage of the agent.</p>
申请公布号 CA2616204(C) 申请公布日期 2015.12.01
申请号 CA20062616204 申请日期 2006.09.11
申请人 LABOPHARM INC.;LABOPHARM EUROPE LIMITED;LABOPHARM (BARBADOS) LIMITED 发明人 GERVAIS, SONIA;SMITH, DAMON;CONTAMIN, PAULINE;OUZEROUROU, RACHID;MA, MY LINH
分类号 A61K47/36;A61K9/22;A61K31/135;A61K31/165;A61K31/496 主分类号 A61K47/36
代理机构 代理人
主权项
地址